EBITDA Margin ratio Analysis of Cardio Diagnostics HLDG WT - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-73295.23
Period Ending - Dec-22
Very Poor EBITDA Margin
-477100.11
Growth
84.64 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-31129.02
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-27234.27
EBITDA Margin Analysis of Cardio Diagnostics HLDG WT
Ebitda Margin Ratio of Cardio Diagnostics HLDG WT with value of -31129.02 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Cardio Diagnostics HLDG WT with value of -27234.27 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of CDIOW rose handsomely by 84.64 % this year. |
Ebitda Margin of Cardio Diagnostics HLDG WT is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of CDIOW that may interest you.
Cardio Diagnostics HLDG WT Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CDIOW | 0.0551 | 0.07 | 21.29 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Cardio Diagnostics HLDG WT
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
---|---|---|---|---|
EBITDA Margin | -73295.23 | -477100.11 | -67086.35 | 0 |
Change | 84.64 % | -611.17 % |
FY Chart of EBITDA Margin of Cardio Diagnostics HLDG WT
Note : All Data Generated at the End of Trading Hours (EOD Data)